Top Markets
#1 Talus Network Talus Network +31.64%
#2 Starpower Starpower +31.04%
#3 Brevis Brevis +30.27%
#4 Keep Network Keep Network +29.44%
#5 Tung Tung Tung Sahur Tung Tung Tung Sahur +25.54%
#6 MemeCore MemeCore +24.60%
#7 Infinity Ground Infinity Ground +22.45%
#8 Allora Allora +21.35%
#9 屎壳郎 (Dung Beetle) 屎壳郎 (Dung Beetle) +17.45%
#10 DeepBook DeepBook +17.40%
Coin of the day
Talus Network Talus Network
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
IntegraGen SA IntegraGen SA

IntegraGen SA

ALINT
Clasificación en acciones #19673
IntegraGen SA provides human genome analysis services for academic researcher... IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; SIRIUS, a cloud-based software tool that enables researchers to analyze whole genome, whole exome, and gene panel sequencing data; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was founded in 2000 and is headquartered in Évry, France. IntegraGen SA is a subsidiary of OncoDNA SA.
Precio por acción
$0.20876331
Capitalización bursátil
$1.38M
Cambio (1 día)
1.15%
Cambio (1 año)
-64.84%
País
FR
Comercio IntegraGen SA (ALINT)

Categoría

Healthcare
Ganancias de IntegraGen SA (ALINT)
Ganancias en Dec 2025 TTM: $-3.23M
Secondo gli ultimi rapporti finanziari di IntegraGen SA, gli utili attuali della società sono $-3.23M. Nel 2023, la società ha registrato un utile di $-286.40K, una disminución en comparación con agli utili del 2022, che erano di $-153.95K. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de IntegraGen SA desde 2008 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
2026 (TTM) $-3.23M 782.69%
2024 $-366.28K 27.89%
2023 $-286.40K 86.04%
2022 $-153.95K 18.42%
2021 $-130.00K -77.17%
2020 $-569.29K 15.84%
2019 $-491.43K -67.91%
2018 $-1.53M 6.75%
2017 $-1.43M -29.04%
2016 $-2.02M 0.08%
2015 $-2.02M 10.76%
2014 $-1.82M -54.01%
2013 $-3.96M 29.95%
2012 $-3.05M -5.30%
2011 $-3.22M -31.40%
2010 $-4.70M -3.84%
2009 $-4.88M -6.08%
2008 $-5.20M 0.00%
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
$24.72B -764,615.67%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.17B -159,875.15%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
$5.16B -159,602.96%
US
UCB SA UCB SA
UCB SA
UCB.BR
$2.14B -66,218.92%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.66B -51,304.66%
NL